RESÚMENES ENERO 2010

.

Child & Adolescent Disorders

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana

 

GRATIS 5< - Structural abnormality of the substantia nigra in children with attention-deficit hyperactivity disorder

Marcel Romanos, David Weise, Mira Schliesser, Martin Schecklmann, , Julia Löffler; Andreas Warnke, , Manfred Gerlach, , Joseph Classen, ,Claudia Mehler-Wex,

J Psychiatry Neurosci 2010;35(1):55-8

 

3 - News Coverage of FDA Warnings on Pediatric Antidepressant Use and Suicidality

Colleen L. Barry, Susan H. Busch

PEDIATRICS Vol. 125 No. 1 January 2010, pp. 88-95

 

3! - Prevalence and Treatment of Mental Disorders Among US Children in the 2001–2004 NHANES

Kathleen Ries Merikangas, Jian-Ping He, Debra Brody, Prudence W. Fisher, Karen Bourdon, Doreen S. Koretz

PEDIATRICS Vol. 125 No. 1 January 2010, pp. 75-81

 

3 - Melatonin Treatment for Insomnia in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder

Lisa M Bendz, Ann C Scates

The Annals of Pharmacotherapy: Vol. 44, No. 1, pp. 185-191

 

5 - A Comparison of the Efficacy of Medications for Adult Attention-Deficit/Hyperactivity Disorder Using Meta-Analysis of Effect Sizes

Stephen V. Faraone, and Stephen J. Glatt

J Clin Psychiatry. Online ahead of print: December 29, 2009

 

5 - Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism

Shahin Akhondzadeh, Jalil Fallah, Mohammad-Reza Mohammadi, Reza Imani, Mohammad Mohammadi, Bahman Salehi, Ahmad Ghanizadeh, Maedeh Raznahan, Soodeh Mohebbi-Rasa, Shams-Ali Rezazadeh and Saeedeh Forghani

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 34, Issue 1, 1 February 2010, Pages 32-36

 

5 - Ginkgo biloba for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized controlled trial

Bahman Salehi, Reza Imani, Mohammad Reza Mohammadi, Jalil Fallah, Mohammad Mohammadi, Ahmad Ghanizadeh, Ali Akbar Tasviechi, Ardalan Vossoughi, Shams-Ali Rezazadeh and Shahin Akhondzadeh

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 34, Issue 1, 1 February 2010, Pages 76-80

 

3! - Neurological and Cardiovascular Adverse Events Associated with Antimanic Treatment in Children and Adolescents

Jeanette M. Jerrell

CNS Neuroscience & Therapeutics. Volume 16 Issue 1, Pages 25 - 31

 

3! - The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: a matched case-control study

Galland BC, Tripp EG, Taylor BJ

J Sleep Res. 2009 Dec 28. [Epub ahead of print]

 

3 - Effect of Leucovorin (Folinic Acid) on the Developmental Quotient of Children with Down's Syndrome (Trisomy 21) and Influence of Thyroid Status

Blehaut H, Mircher C, Ravel A, Conte M, de Portzamparc V, et al.

PLoS ONE 2010; 5(1): e8394

 

3! - Adult Psychiatric Outcomes of Girls With Attention Deficit Hyperactivity Disorder: 11-Year Follow-Up in a Longitudinal Case-Control Study

Joseph Biederman, Carter R. Petty, Michael C. Monuteaux, Ronna Fried, Deirdre Byrne, Tara Mirto, Thomas Spencer, Timothy E. Wilens, and Stephen V. Faraone

Am J Psychiatry Published January 15, 2010

3! - Psychiatric Disorders in Preschool Offspring of Parents With Bipolar Disorder: The Pittsburgh Bipolar Offspring Study (BIOS)

Boris Birmaher, David Axelson, Benjamin Goldstein, Kelly Monk, Catherine Kalas, Mihaela Obreja, Mary Beth Hickey, Satish Iyengar, David Brent, Wael Shamseddeen, Rasim Diler, and David Kupfer

Am J Psychiatry Published January 15, 2010

GRATIS 3! - Evidence-Based Use of Second-Generation Antipsychotics in a State Medicaid Pediatric Population, 2001–2005

Prathamesh Pathak, Donna West, Bradley C. Martin, Mark E. Helm, and Crystal Henderson

Psychiatr Serv 61:123-129, February 2010

 

3 - Modifying the risk of atypical antipsychotics in the treatment of juvenile-onset schizophrenia

Lisa Townsend & Robert L Findling

Expert Opinion on Pharmacotherapy. February 2010, Vol. 11, No. 2, Pages 195-205

 

3 - Pharmacotherapy of major depressive disorder in adolescents

Gabriele Masi , Francesca Liboni   & Paola Brovedani

Expert Opinion on Pharmacotherapy. February 2010, Vol. 11, No. 3, Pages 375-386

 

GRATIS (previo registro) 3 - Avances en el trastorno por déficit de atención e hiperactividad.¿Qué nos aporta la neuroimagen?

J. Quintero,  M. Navas,  A. Fernández y T. Ortiz

Actas Esp Psiquiatr 2009;37(6):352-358

 

GRATIS 3 - How Does This Happen? Part I: Mechanisms of Adverse Drug Reactions Associated with Psychotropic Medications

Dean Elbe; Robert Savage

J Can Acad Child Adolesc Psychiatry 19:1 February 2010: 40

 

 

 



Regresar a RESÚMENES ENERO 2010


© 1999-2010 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

 

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA